DOCSLIB.ORG

Dissociated Presenilin-1 and TACE Processing of Erbb4 in Lung Alveolar Type II Cell Differentiation

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Dissociated Presenilin-1 and TACE Processing of Erbb4 in Lung Alveolar Type II Cell Differentiation View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Biochimica et Biophysica Acta 1843 (2014) 797–805 Contents lists available at ScienceDirect Biochimica et Biophysica Acta journal homepage: www.elsevier.com/locate/bbamcr Dissociated presenilin-1 and TACE processing of ErbB4 in lung alveolar type II cell differentiation Najla Fiaturi a,⁎, Anika Ritzkat b,c, Christiane E.L. Dammann b,c,d, John J. Castellot a,d,1, Heber C. Nielsen b,d,1 a Program in Pharmacology and Experimental Therapeutics, Department of Integrative Physiology and Pathobiology, Sackler School of Graduate Biomedical Studies, Tufts University, Boston, MA 02111, USA b Department of Pediatrics, Tufts Medical Center, Boston, MA 02111 USA c Hannover Medical School, Hannover, Germany d Graduate Program in Cell, Molecular and Developmental Biology, Department of Integrative Physiology and Pathobiology, Sackler School of Graduate Biomedical Studies, Tufts University, Boston, MA 02111, USA article info abstract Article history: Neuregulin (NRG) stimulation of ErbB4 signaling is important for type II cell surfactant synthesis. ErbB4 may me- Received 25 October 2013 diate gene expression via a non-canonical pathway involving enzymatic cleavage releasing its intracellular do- Received in revised form 18 December 2013 main (4ICD) for nuclear trafficking and gene regulation. The accepted model for release of 4ICD is consecutive Accepted 13 January 2014 cleavage by Tumor necrosis factor alpha Converting Enzyme (TACE) and γ-secretase enzymes. Here, we show Available online 24 January 2014 that 4ICD mediates surfactant synthesis and its release by γ-secretase is not dependent on previous TACE cleav- age. We used siRNA to silence Presenilin-1 (PSEN-1) expression in a mouse lung type II epithelial cell line (MLE12 Keywords: fi ErbB receptor cells), and both siRNA knockdown and chemical inhibition of TACE. Knockdown of PSEN-1 signi cantly de- Gamma secretase creased baseline and NRG-stimulated surfactant phospholipid synthesis, expression of the surfactant proteins Presenilin-1 SP-B and SP-C, as well as 4ICD levels, with no change in ErbB4 ectodomain shedding. Neither siRNA knockdown Neonatal lung nor chemical inhibition of TACE inhibited 4ICD release or surfactant synthesis. PSEN-1 cleavage of ErbB4 for non- Type II cell canonical signaling through 4ICD release does not require prior cleavage by TACE. Surfactant protein © 2014 Elsevier B.V. All rights reserved. 1. Introduction expressed by type II cells, play a prominent role in stimulation of type II cell maturation and surfactant synthesis [4,5]. NRG is expressed in Respiratory distress syndrome (RDS), formerly known as hyaline the midtrimester human fetal lung [6] and increases in fetal lung at membrane disease, is a common problem in preterm infants born be- the onset of surfactant synthesis [7]. fore 28 weeks. This disease is caused primarily by deficiency of pulmo- ErbB4 is a member of the ErbB receptor tyrosine kinase family, nary surfactant in immature lungs and is more common the earlier the which also includes the epidermal growth factor receptor, also called infant is born [1]. Despite the beneficial effects of prenatal glucocorti- ErbB1, ErbB2, and ErbB3 [8]. The ErbB receptors are transmembrane ty- coids and postnatal surfactant replacement therapies, RDS remains rosine kinase proteins and act as important regulators of cell prolifera- one of the significant causes of morbidity and mortality in premature in- tion and differentiation during fetal organ development including lung fants [2,1]. Pulmonary surfactant is a mixture of surface active phospho- development [9]. ErbB4 signal transduction is a complex process that in- lipids and proteins (termed surfactant protein B (SP-B) and SP-C) which volves both canonical and non-canonical signaling pathways. Binding of is produced in alveolar type II epithelial cells [3]. The development of NRG to its extracellular ligand-binding site causes ErbB4 to form homo surfactant synthesis is under multifactorial control, in which paracrine or heterodimers with other ErbB receptors linked by disulfide bonds mesenchyme-type II cell communication mechanisms play a central in the extracellular domain [10]. These receptor dimers then undergo role. We have shown that the growth factor Neuregulin (NRG-1), auto phosphorylation on tyrosine residues within the intracellular do- which is secreted by fibroblasts, and its target receptor ErbB4, which is main. In the canonical signal pathway tyrosine phosphorylation acti- vates signal cascades through specific intracellular signaling pathways such as the phosphatidylinositol-3 (PI3) Kinase/Akt pathway to ulti- Abbreviations: SP-B, Surfactant protein B; SP-C, Surfactant protein C; NRG-1, fl Neuregulin-1; TACE, Tumor necrosis factor alpha converting enzyme; DSPC, Disaturated mately in uence gene expression [11]. However, within the ErbB fami- phosphatidyl choline ly, ErbB4 is unique in that it may undergo proteolytic processing to ⁎ Corresponding author at: 136 Harrison Ave., Tufts University, Boston, MA 02148, USA. initiate non-canonical signaling [12]. The accepted model for the non- Tel.: +1 781 228 9652. canonical pathway involves two sequential cleavage processes. The fi E-mail addresses: naj [email protected] (N. Fiaturi), [email protected] (A. Ritzkat), fi [email protected] (C.E.L. Dammann), [email protected] rst step in this pathway is performed by a transmembrane (J.J. Castellot), [email protected] (H.C. Nielsen). metalloprotease Tumor necrosis factor alpha Converting Enzyme 1 Co-senior authors. (TACE) which releases the ErbB4 ectodomain by a cleavage that 0167-4889/$ – see front matter © 2014 Elsevier B.V. All rights reserved. http://dx.doi.org/10.1016/j.bbamcr.2014.01.015 798 N. Fiaturi et al. / Biochimica et Biophysica Acta 1843 (2014) 797–805 produces two fragments: a 120 kDa ectodomain fragment which is Millipore (Billerica, MA). Anti-prosurfactant protein C (rabbit polyclonal released into the extracellular space and an 80 kDa membrane- antibody, ab90716), anti-prosurfactant protein B (rabbit polyclonal anti- associated fragment that contains the ErbB4 transmembrane domain body ab15011), monoclonal antibody to beta actin (HRP conjugated, and the entire cytoplasmic region, including the tyrosine kinase domain. cat# 20272), Anti-TACE antibody (rabbit polyclonal antibody, cat# Ectodomain cleavage of ErbB4 in cells occurs at a low constitutive or ab2051) were all from Abcam (Cambridge, MA). Peroxidase-conjugated basal level [13] that can be increased by neuregulin or other ErbB4 Affinipure Goat Anti-Rabbit IgG (H + L), (111-035-144) was from Jackson ligands [14]. The ectodomain cleavage of ErbB4 is sensitive to ImmunoResearch. Anti-ERBb4 antibody (cat# sc-283) was obtained from metalloprotease inhibitors [13] and does not occur in cells genetically Santa Cruz (Santa Cruz, CA). Chloroform (spectrophotometric grade) was deficient in TACE. The ErbB4 m80 fragment (membrane associated frag- obtained from Sigma Aldrich (St Louis, MO). Methanol was from Fisher ment) that remains following ectodomain cleavage is further processed Scientific; Silica gel H thin layer chromatography sheets were from by γ-secretase that cleaves at the transmembrane domain to release a Analtech (Newark, DE). Osmium tetroxide 05500-1G, carbon tetrachlo- soluble intracellular s80 fragment (4ICD) into the cytosol from which ride and dipalmitoylphosphatidyl choline (P-5911) were from Sigma it translocates to the nucleus in association with chaperone proteins Aldrich (St Louis, MO). Ultima-Gold scintillation fluid was from Perkin [14,15]. Gamma secretase is an enzyme complex which consists of 4 Elmer (Waltham, MA). For centrifugation we used a Beckman J-6 M. components: presenilin 1 (PSEN-1) or Presenilin 2 (PSEN-2), Nycastrin, anterior pharynx defective-1 (APH-1) and the Presenilin-Enhancer 2. PSEN-1 or PSEN-2 are the active enzymatic component; other compo- 2.2. Cell culture nents behave as scaffolding molecules and essential cofactors [16–19]. Studies with transgenic mice show that PSEN-1 and PSEN-2 have func- MLE12 cells were used as a model for type II alveolar epithelial tionally distinct phenotypes in several organs including the lung cells. MLE12 cells exhibit characteristics of alveolar type II cells, in- [20,21]. cluding the expression of SP-B and SP-C and formation of microvilli Nuclear localization of ErbB4 is the preferred mechanism of ErbB4 and multivesicular bodies. They have a strong response to fetal signaling in several regulatory processes during development [22].The fibroblast-conditioned media (FCM) and NRG with increased DPSC accepted model for γ-secretase activity in ErbB4 processing is that synthesis [7,24]. MLE-12 cells were grown in DMEM containing ectodomain cleavage by TACE is a prerequisite step [12]. In this study 10% FBS, 2% pen/strep and 2% L-glutamine. Media were changed we sought to more specifically define the sequential interactive relation- every second day. ship of PSEN-1 and TACE for ErbB4 processing controlling lung alveolar type II cell surfactant production. Our focus on PSEN-1 was motivated by the more severe developmental phenotype of alveolar maturation in 2.3. Transfection with siRNA the PSEN-1 knockout mouse compared to the PSEN-2 knock out and our previous work showing the importance of PSEN-1 signaling for MLE12 cells were transfected with siRNA using the transfection re- fetal type II cell maturation [22,23]. We studied the effect of PSEN-1 agent Dharmafect 2. To knock down presenilin 1, three pre-designed knockdown and TACE knockdown in MLE12 cells and evaluated the ef- Presenilin-1 siRNA sequences that target three different regions of fects on ErbB4 cleavage in association with the expression of the SP-B Presenilin mRNA were used. To knock down TACE we used a cocktail and SP-C mRNA and protein and synthesis of the major surfactant phos- of 3 siRNAs targeting the TACE gene. The protocol for transfection of pholipid disaturated phosphatidylcholine (DSPC). MLE12 cells was adapted from the manufacturer's guidelines; all steps were done using RNAse-free pipette tips and RNase spray for 2.
Load more

Recommended publications
  • 343747488.Pdf
    Washington University School of Medicine Digital Commons@Becker Open Access Publications 6-1-2020 Systematic validation of variants of unknown significance in APP, PSEN1 and PSEN2 Simon Hsu Anna A Pimenova Kimberly Hayes Juan A Villa Matthew J Rosene See next page for additional authors Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs Authors Simon Hsu, Anna A Pimenova, Kimberly Hayes, Juan A Villa, Matthew J Rosene, Madhavi Jere, Alison M Goate, and Celeste M Karch Neurobiology of Disease 139 (2020) 104817 Contents lists available at ScienceDirect Neurobiology of Disease journal homepage: www.elsevier.com/locate/ynbdi Systematic validation of variants of unknown significance in APP, PSEN1 T and PSEN2 Simon Hsua, Anna A. Pimenovab, Kimberly Hayesa, Juan A. Villaa, Matthew J. Rosenea, ⁎ Madhavi Jerea, Alison M. Goateb, Celeste M. Karcha, a Department of Psychiatry, Washington University School of Medicine, 425 S Euclid Avenue, St Louis, MO 63110, USA b Department of Neuroscience, Mount Sinai School of Medicine, New York, NY, USA ARTICLE INFO ABSTRACT Keywords: Alzheimer's disease (AD) is a neurodegenerative disease that is clinically characterized by progressive cognitive APP decline. More than 200 pathogenic mutations have been identified in amyloid-β precursor protein (APP), presenilin PSEN1 1 (PSEN1) and presenilin 2 (PSEN2). Additionally, common and rare variants occur within APP, PSEN1, and PSEN2 PSEN2 that may be risk factors, protective factors, or benign, non-pathogenic polymorphisms. Yet, to date, no Alzheimer's disease single study has carefully examined the effect of all of the variants of unknown significance reported in APP, Cell-based assays PSEN1 and PSEN2 on Aβ isoform levels in vitro.
    [Show full text]
  • Genetic Testing for Familial Alzheimer's Disease
    Corporate Medical Policy Genetic Testing for Familial Alzheimer’s Disease AHS – M2038 File Name: genetic_testing_for_familial_alzheimers_disease Origination: 1/2019 Last CAP Review: 10/2020 Next CAP Review: 10/2021 Last Review: 10/2020 Description of Procedure or Service Alzheimer disease (AD) is a neurodegenerative disease defined by a gradual decline in memory, cognitive functions, gross atrophy of the brain, and an accumulation of extracellular amyloid plaques and intracellular neurofibrillary tangles (Karch, Cruchaga, & Goate, 2014). Familial Alzheimer disease (FAD) is a rare, inherited form of AD. FAD has a much earlier onset than other forms of Alzheimer disease with symptoms developing in individuals in their thirties or forties. Related Policies General Genetic Testing, Germline Disorders AHS – M2145 General Genetic Testing, Somatic Disorders AHS – M2146 ***Note: This Medical Policy is complex and technical. For questions concerning the technical language and/or specific clinical indications for its use, please consult your physician. Policy BCBSNC will provide coverage for genetic testing for familial Alzheimer disease when it is determined the medical criteria or reimbursement guidelines below are met. Benefits Application This medical policy relates only to the services or supplies described herein. Please refer to the Member's Benefit Booklet for availability of benefits. Member's benefits may vary according to benefit design; therefore member benefit language should be reviewed before applying the terms of this medical policy.
    [Show full text]
  • Membrane Topology of the C. Elegans SEL-12 Presenilin
    Neuron, Vol. 17, 1015±1021, November, 1996, Copyright 1996 by Cell Press Membrane Topology of the C. elegans SEL-12 Presenilin Xiajun Li* and Iva Greenwald*²³ [this issue of Neuron]; Thinakaran et al., 1996). In the *Integrated Program in Cellular, Molecular, Discussion, we examine the amino acid sequence in and Biophysical Studies light of the deduced topology. ² Department of Biochemistry and Molecular Biophysics Results ³ Howard Hughes Medical Institute Columbia University Sequence analysis suggests that SEL-12 and human College of Physicians and Surgeons presenilins have ten hydrophobic regions (Figure 1). In New York, New York 10032 this study, we provide evidence that a total of eight of these hydrophobic regions function as transmembrane domains in vivo. Below, we use the term ªhydrophobic Summary regionº to designate a segment of the protein with the potential to span the membrane, as inferred by hydro- Mutant presenilins cause Alzheimer's disease. Pre- phobicity analysis, and ªtransmembrane domainº to senilins have multiple hydrophobic regions that could designate a hydrophobic region that our data suggest theoretically span a membrane, and a knowledge of actually spans a membrane. the membrane topology is crucial for deducing the mechanism of presenilin function. By analyzing the activity of b-galactosidase hybrid proteins expressed Strategy in C. elegans, we show that the C. elegans SEL-12 We constructed transgenes encoding hybrid SEL- presenilin has eight transmembrane domains and that 12::LacZ proteins, in which LacZ was placed after each there is a cleavage site after the sixth transmembrane of ten hydrophobic regions identified by hydrophobicity domain. We examine the presenilin sequence in view analysis (see Figure 1).
    [Show full text]
  • Cerebrospinal Fluid Biomarkers for Differentiating Between Alzheimer‟S Disease and Vascular Dementia
    Cerebrospinal fluid biomarkers for differentiating between Alzheimer‟s disease and Vascular dementia Maria Bjerke Institute of Neuroscience and Physiology Department of Psychiatry and Neurochemistry The Sahlgrenska Academy Gothenburg University 2011 ISBN 978-91-628-8312-6 © Maria Bjerke Institute of Neuroscience and Physiology Gothenburg University Sweden Printed at Intellecta Infolog Gothenburg Sweden, 2011 To my family ABSTRACT Patients suffering from mild cognitive impairment (MCI) run a higher risk of developing dementia, with Alzheimer‟s disease (AD) being the most common form. Vascular dementia (VaD) is proposed to be the second most common dementia entity, and it includes the clinically relatively homogenous subgroup of subcortical vascular dementia (SVD). Varying degrees of concomitant vascular lesions represent a link between AD and VaD, comprising a state of mixed dementia (MD). Biochemical markers provide important information which may contribute to differentiating between dementias of different etiologies, and in combination with the clinical assessment may improve diagnostic accuracy. The overall aim of this thesis is to provide for better separation between patients suffering from SVD and AD with the aid of biochemical markers. The cerebrospinal fluid (CSF) biomarkers T-tau, P-tau181, and Aβ1-42, have proven useful in distinguishing MCI patients who ultimately develop AD (MCI-AD) at follow-up from those who remain stable. However, less is known about the biomarker pattern in MCI patients who develop SVD (MCI-SVD). An elevated baseline level of NF-L was found in MCI-SVD patients compared with stable MCI patients, while MCI-AD had decreased levels of Aβ1-42 and increased levels of T- tau and P-tau181 compared with MCI-SVD patients and stable MCI patients.
    [Show full text]
  • Differential Gene Expression in Oligodendrocyte Progenitor Cells, Oligodendrocytes and Type II Astrocytes
    Tohoku J. Exp. Med., 2011,Differential 223, 161-176 Gene Expression in OPCs, Oligodendrocytes and Type II Astrocytes 161 Differential Gene Expression in Oligodendrocyte Progenitor Cells, Oligodendrocytes and Type II Astrocytes Jian-Guo Hu,1,2,* Yan-Xia Wang,3,* Jian-Sheng Zhou,2 Chang-Jie Chen,4 Feng-Chao Wang,1 Xing-Wu Li1 and He-Zuo Lü1,2 1Department of Clinical Laboratory Science, The First Affiliated Hospital of Bengbu Medical College, Bengbu, P.R. China 2Anhui Key Laboratory of Tissue Transplantation, Bengbu Medical College, Bengbu, P.R. China 3Department of Neurobiology, Shanghai Jiaotong University School of Medicine, Shanghai, P.R. China 4Department of Laboratory Medicine, Bengbu Medical College, Bengbu, P.R. China Oligodendrocyte precursor cells (OPCs) are bipotential progenitor cells that can differentiate into myelin-forming oligodendrocytes or functionally undetermined type II astrocytes. Transplantation of OPCs is an attractive therapy for demyelinating diseases. However, due to their bipotential differentiation potential, the majority of OPCs differentiate into astrocytes at transplanted sites. It is therefore important to understand the molecular mechanisms that regulate the transition from OPCs to oligodendrocytes or astrocytes. In this study, we isolated OPCs from the spinal cords of rat embryos (16 days old) and induced them to differentiate into oligodendrocytes or type II astrocytes in the absence or presence of 10% fetal bovine serum, respectively. RNAs were extracted from each cell population and hybridized to GeneChip with 28,700 rat genes. Using the criterion of fold change > 4 in the expression level, we identified 83 genes that were up-regulated and 89 genes that were down-regulated in oligodendrocytes, and 92 genes that were up-regulated and 86 that were down-regulated in type II astrocytes compared with OPCs.
    [Show full text]
  • 1 Presenilin-Based Genetic Screens in Drosophila Melanogaster Identify
    Genetics: Published Articles Ahead of Print, published on January 16, 2006 as 10.1534/genetics.104.035170 Presenilin-based genetic screens in Drosophila melanogaster identify novel Notch pathway modifiers Matt B. Mahoney*1, Annette L. Parks*2, David A. Ruddy*3, Stanley Y. K. Tiong*, Hanife Esengil4, Alexander C. Phan5, Panos Philandrinos6, Christopher G. Winter7, Kari Huppert8, William W. Fisher9, Lynn L’Archeveque10, Felipa A. Mapa11, Wendy Woo, Michael C. Ellis12, Daniel Curtis11 Exelixis, Inc., South San Francisco, California, 94083 Present addresses: 1Department of Discovery, EnVivo Pharmaceuticals, Watertown, Massachusetts, 02472 2Biology Department, Boston College, Chestnut Hill, Massachusetts, 02467 3Oncology Targets and Biomarkers, Novartis Institutes for BioMedical Research, Inc., Cambridge, Massachusetts, 02139 4Department of Molecular Pharmacology, Stanford University, Stanford, California, 94305 5Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, 21205 6ITHAKA Academic Cultural Program in Greece, San Francisco, California, 94102 7Merck Research Laboratories, Boston, Massachusetts, 02115 8Donald Danforth Plant Science Center, St. Louis, Missouri, 63132 1 9Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, California, 94720 10Biocompare, Inc., South San Francisco, California, 94080 11Developmental and Molecular Pathways, Novartis Institutes for BioMedical Research, Inc., Cambridge, Massachusetts, 02139 12Renovis, Inc., South San Francisco, California, 94080
    [Show full text]
  • The Use of Antimicrobial and Antiviral Drugs in Alzheimer's Disease
    International Journal of Molecular Sciences Review The Use of Antimicrobial and Antiviral Drugs in Alzheimer’s Disease Umar H. Iqbal, Emma Zeng and Giulio M. Pasinetti * Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; [email protected] (U.H.I.); [email protected] (E.Z.) * Correspondence: [email protected]; Tel.: +1-212-241-7938 Received: 29 May 2020; Accepted: 10 July 2020; Published: 12 July 2020 Abstract: The aggregation and accumulation of amyloid-β plaques and tau proteins in the brain have been central characteristics in the pathophysiology of Alzheimer’s disease (AD), making them the focus of most of the research exploring potential therapeutics for this neurodegenerative disease. With success in interventions aimed at depleting amyloid-β peptides being limited at best, a greater understanding of the physiological role of amyloid-β peptides is needed. The development of amyloid-β plaques has been determined to occur 10–20 years prior to AD symptom manifestation, hence earlier interventions might be necessary to address presymptomatic AD. Furthermore, recent studies have suggested that amyloid-β peptides may play a role in innate immunity as an antimicrobial peptide. These findings, coupled with the evidence of pathogens such as viruses and bacteria in AD brains, suggests that the buildup of amyloid-β plaques could be a response to the presence of viruses and bacteria. This has led to the foundation of the antimicrobial hypothesis for AD. The present review will highlight the current understanding of amyloid-β, and the role of bacteria and viruses in AD, and will also explore the therapeutic potential of antimicrobial and antiviral drugs in Alzheimer’s disease.
    [Show full text]
  • “The Use of CRISPR Technology to Test Gene Therapy As a Treatment
    The Dana Foundation’s “Design a Brain Experiment” Competition 2017 First Place “The Use of CRISPR Technology to Test Gene Therapy as a Treatment to Early-Onset Familial Alzheimer’s Disease in Zebrafish” By Medha Palnati Westford Academy, Massachusetts Lay Summary (provided by the Dana Foundation): Early- onset Familial Alzheimer’s disease (FAD), which occurs in about five percent of all people with AD, develop the disease sometime between age 30 and 60. Usually FAD is caused by an inherited mutation in one of three genes. An infant born to a parent who carries the genetic mutation has a 50 percent chance of inheriting that mutation; an infant that inherits it has a strong likelihood of developing early-onset FAD. Any of several different single gene mutations on chromosomes 21, 14, and 1 causes abnormal protein formation. A mutation on chromosome 21 results in formation of abnormal amyloid precursor protein (APP), while a mutation on chromosome 14 or 1 produces abnormal presenilin 1 or presenilin 2, respectively. Each contributes to APP breakdown, generating accumulation of harmful amyloid plaques between brain cells that eventually disrupt communication from one cell to another. Medha’s experiment explores the potential of using an exciting new experimental form of gene therapy to treat FAD. To test this potential therapy, she uses the transgenic zebrafish model which has “ortholog” genes psen1, psen2, and appa and appb that can be individually manipulated using this experimental gene therapy called CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats). CRISPR is a unique technology for editing parts of the genome by removing, adding, or altering sections of the DNA sequence.
    [Show full text]
  • PMP22 Earrying the Trembler Or Tremblerj Mutation Is Intracellularly Retained in Myelinating Schwann Cells in Vivo
    PMP22 earrying the Trembler or TremblerJ mutation is intracellularly retained in myelinating Schwann cells in vivo by: Joshua Joseph Colby Center for Neuronal Survival Montreal Neurological Institute De partment of Pathology McGill University Montreai, Quebec, Canada Submitted in March, 2000 A thesis submitted to the Faculty of Graduate Studies and Research in partial Mfillment of the requirements for the degree of Master of Science (Pathology) O Joshua Colby, 2000 National Library Biiiothbque nationale du Canada Acquisitions arid Acquisitions et Bibliraphic Services services bibliographiques 395 W.lingtori Street 395. rwWeYingiMi OtIawaON KlAW OWawaON KlAONQ canada Canada The author has granteci a non- L'auteur a accordé une licence non exclusive licence aUowing the exclusive permettant à la National Lhrary of Canada to Bibliothèque nationaie du Canada de reproduce, 10- distri'bute or seii reproduire, prêter, distribuer ou copies of this thesis in microform, vendre des copies de cette thèse sous paper or electronic formats. la forme de microfiche/nIm, de reproduction sur papier ou sur format électronique. The author retains ownership of the L'autwr conserve la propriété du copyright in this thesis. Neither the droit d'auteur qui protège cette thèse. thesis nor substantial extracts fiom it Ni la îhèse ni des extraits substantiels may be printed or othecwise de celle-ci ne doivent être imprimés reproduced without the author's ou autrement reproduits saus son permission. autorisation. The most common cause of human hereditary neuropathies is a duplication in the peripheral myelin protein-22 (PMP22) gene. PM.22 is an integral membrane glycoprotein expressed primdy in the compact myelin of the mammalian peripheral nervous system.
    [Show full text]
  • Interorganelle Communication, Aging, and Neurodegeneration
    Downloaded from genesdev.cshlp.org on October 9, 2021 - Published by Cold Spring Harbor Laboratory Press REVIEW Interorganelle communication, aging, and neurodegeneration Maja Petkovic,1 Caitlin E. O’Brien,2 and Yuh Nung Jan1,2,3 1Department of Physiology, University of California at San Francisco, San Francisco, California 94158, USA; 2Howard Hughes Medical Institute, University of California at San Francisco, San Francisco, California 94158, USA; 3Department of Biochemistry and Biophysics, University of California at San Francisco, San Francisco, California 94158, USA Our cells are comprised of billions of proteins, lipids, and ular transport cannot account for the exchange of certain other small molecules packed into their respective subcel- biomolecules. For example, delivery of several classes of lip- lular organelles, with the daunting task of maintaining cel- ids from their site of synthesis in the endoplasmic reticu- lular homeostasis over a lifetime. However, it is becoming lum (ER) to their steady-state location is unaffected by increasingly evident that organelles do not act as autono- pharmacological and genetic manipulations that deplete mous discrete units but rather as interconnected hubs cellular ATP levels, disrupt vesicular transport, and alter that engage in extensive communication through mem- cytoskeletal dynamics (Kaplan and Simoni 1985; Vance brane contacts. In the last few years, our understanding et al. 1991; Hanada et al. 2003; Baumann et al. 2005; Lev of how these contacts coordinate organelle function has re- 2012). Moreover, intracellular compartments like the ER defined our view of the cell. This review aims to present and mitochondria refill their depleted calcium (Ca2+) stores novel findings on the cellular interorganelle communica- through low-affinity calcium channels that require much tion network and how its dysfunction may contribute to higher local concentrations of calcium than global cytosol- aging and neurodegeneration.
    [Show full text]
  • Autoimmune Encephalomyelitis and Uveitis Induced by T Cell Immunity to Self ␤-Synuclein1
    The Journal of Immunology Autoimmune Encephalomyelitis and Uveitis Induced by T Cell Immunity to Self ␤-Synuclein1 Felix Mor,2 Francisco Quintana, Avishai Mimran, and Irun R. Cohen ␤-synuclein is a neuronal protein that accumulates in the plaques that characterize neurodegenerative diseases such as Parkinson’s and Alzheimer’s diseases. It has been proposed that immunization to peptides of plaque-forming proteins might be used thera- peutically to help dissociate pathogenic plaques in the brain. We now report that immunization of Lewis rats with a peptide from ␤-synuclein resulted in acute paralytic encephalomyelitis and uveitis. T cell lines and clones reactive to the peptide adoptively transferred the disease to naive rats. Immunoblotting revealed the presence of ␤-synuclein in heavy myelin, indicating that the expression of ␤-synuclein is not confined to neurons. These results add ␤-synuclein to the roster of encephalitogenic self Ags, point out the potential danger of therapeutic autoimmunization to ␤-synuclein, and alert us to the unsuspected possibility that auto- immunity to ␤-synuclein might play an inflammatory role in the pathogenesis of neurodegeneration. The Journal of Immunology, 2003, 170: 628–634. arkinson’s and Alzheimer’s diseases are common human in Lewis rats; T cell lines could be generated to them; immuniza- neurodegenerative disorders in which abnormal aggre- tion to self ␤-synuclein induced acute paralytic encephalomyelitis; P gates of proteins accumulate in the brain, resulting in neu- and uveitis could be adoptively transferred with T cell line and rotoxicity and apoptosis (1, 2). The success of immune therapy in clones specific for ␤-synuclein that was detected by Western blot a mouse model of Alzheimer’s disease (3–5) has prompted clinical in myelin.
    [Show full text]
  • PRESENILIN 1 Mutations Causing Early-Onset Familial Alzheimer's
    bioRxiv preprint doi: https://doi.org/10.1101/2021.01.26.428321; this version posted February 9, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC 4.0 International license. 1 PRESENILIN 1 mutations causing early-onset familial Alzheimer’s 2 disease or familial acne inversa differ in their effects on genes 3 facilitating energy metabolism and signal transduction 4 Karissa Barthelsona*, Yang Donga, Morgan Newmana and Michael Lardellia 5 a Alzheimer’s Disease Genetics Laboratory, School of Biological Sciences, University of 6 Adelaide, North Terrace, Adelaide, SA 5005, Australia 7 * Corresponding author 8 Complete correspondence address: Room 1.24, Molecular Life Sciences Building. North 9 Terrace Campus. The University of Adelaide, SA 5005, Australia. 10 Telephone: 83134863 11 Email: [email protected] 12 Running title: RNA-seq analysis of psen1 mutations 13 14 1 bioRxiv preprint doi: https://doi.org/10.1101/2021.01.26.428321; this version posted February 9, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC 4.0 International license. 15 ABSTRACT 16 Background: The most common cause of early-onset familial Alzheimer’s disease (EOfAD) is 17 mutations in PRESENILIN 1 (PSEN1) allowing production of mRNAs encoding full-length, but 18 mutant, proteins. In contrast, a single known frameshift mutation in PSEN1 causes familial 19 acne inversa (fAI) without EOfAD.
    [Show full text]